Literature DB >> 20237874

Evaluation of the risk of radiation exposure from new 18FDG PET/CT plans versus conventional X-ray plans in patients with pediatric cancers.

Takeshi Murano1, Ukihide Tateishi, Takeshi Iinuma, Naoki Shimada, Hiromitsu Daisaki, Takashi Terauchi, Noriyuki Moriyama, Tomio Inoue.   

Abstract

OBJECTIVE: Unnecessary radiological examination should be avoided, particularly for children, who are more vulnerable to radiation than adults. Replacement of X-ray examination with 18F-fluoro-2-deoxy-D-glucose (18FDG) positron emission tomography/computed tomography (PET/CT) is a potential option for reduction of radiation exposure, and thus improvement in the quality of life (QOL) of patients. Therefore, this study aimed to evaluate new plans integrating 18FDG PET/CT versus current conventional imaging (CI) plans for patients with pediatric cancers. The effects of radiation exposure from the two kinds of plans were compared using shortening of the average life expectancy as an index, and the related findings and effects of radiation exposure are discussed.
METHODS: Effective radiation doses from CT scanning were calculated using the ImPACT CT Patient Dosimetry Calculator software. Radiation doses in different organs and tissues from radiopharmaceuticals were obtained from the International Commission on Radiological Protection (ICRP) publication 80. Shortening of average life expectancy was calculated using software in which the linear non-threshold model (LNT) by the ICRP was adopted.
RESULTS: In current CI plans, the mean effective dose was 168.8 mSv (range 50.5-513.4 mSv) for males and 127 mSv (range 54-239.7 mSv) for females. The mean shortening of average life expectancy was 177 days (range 53.3-542 days) for males and 185 days (range 80.4-371 days) for females. In new plans, the mean effective dose was 64.1 mSv (range 54.1-84.5 mSv) for males and 68.2 mSv (range 58.1-88.0 mSv) for females. The mean shortening of life expectancy was 67.6 days (range 57.1-89.2 days) for males and 102.5 days (range 86.8-132.6 days) for females.
CONCLUSIONS: New 18FDG PET/CT plans may relieve the patient's physical burden and contribute to improvement of the patient's QOL. These plans may also reduce medical costs because the number of examinations to be performed is reduced. Although deterministic effects are not observed in the CI plan, careful attention should be paid to other potential effects. Because the effective dose resulting from this plan is over 100 mSv, at which stochastic effects are known to occur, radiation-induced cancers may be expected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237874     DOI: 10.1007/s12149-010-0342-5

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  8 in total

Review 1.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 2.  Positron emission tomography for benign and malignant disease.

Authors:  Anthony Visioni; Julian Kim
Journal:  Surg Clin North Am       Date:  2011-02       Impact factor: 2.741

3.  Low-dose radiation protocol using 3D mode in a BGO PET/CT.

Authors:  Solange A Nogueira; Renato Dimenstein; Marcelo L Cunha; Jairo Wagner; Marcelo B G Funari; Henrique M Lederman
Journal:  Radiol Med       Date:  2014-06-06       Impact factor: 3.469

4.  Comparison of effective radiation doses from X-ray, CT, and PET/CT in pediatric patients with neuroblastoma using a dose monitoring program.

Authors:  Yeun Yoon Kim; Hyun Joo Shin; Myung Joon Kim; Mi-Jung Lee
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

Review 5.  Dual-Mode Tumor Imaging Using Probes That Are Responsive to Hypoxia-Induced Pathological Conditions.

Authors:  S A Amali S Subasinghe; Robia G Pautler; Md Abul Hassan Samee; Jason T Yustein; Matthew J Allen
Journal:  Biosensors (Basel)       Date:  2022-06-30

6.  Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable?

Authors:  Minoo Battiwalla; Farhad Fakhrejahani; Natasha A Jain; Jeffrey K Klotz; Priyanka A Pophali; Debbie Draper; Janice Haggerty; Zachariah McIver; James Jelinek; Kamna Chawla; Sawa Ito; John Barrett
Journal:  Hematology       Date:  2013-11-25       Impact factor: 2.269

7.  Use of subsequent PET/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy.

Authors:  Xu Zhang; Wei Fan; Zhong-Jun Xia; Ying-Ying Hu; Xiao-Ping Lin; Ya-Rui Zhang; Zhi-Ming Li; Pei-Yan Liang; Yuan-Hua Li
Journal:  Chin J Cancer       Date:  2014-11-21

8.  Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan.

Authors:  Hiroaki Sagara; Kazumasa Inoue; Hideki Yaku; Amon Ohsawa; Takashi Someya; Kaori Yanagisawa; Shuhei Ohashi; Rikuta Ishigaki; Masashi Wakabayashi; Yoshihisa Muramatsu; Hirofumi Fujii
Journal:  Ann Nucl Med       Date:  2021-07-21       Impact factor: 2.668

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.